• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产儿远端肺上皮成熟:早产儿的肺在出生后是否继续其功能性肺发育?

Distal pulmonary epithelial maturation in preterm infants: does the lung of the preterm infant continue its functional pulmonary development postnatally?

作者信息

Chirculescu Raluca, Balanescu Paul Cristian, Peltecu Gheorghe

机构信息

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Department of Pathology, Filantropia Clinical Hospital, Bucharest, Romania.

出版信息

J Med Life. 2025 May;18(5):478-486. doi: 10.25122/jml-2025-0072.

DOI:10.25122/jml-2025-0072
PMID:40599141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12207692/
Abstract

Disruption of pulmonary development caused by premature birth before the achievement of functional pulmonary maturation culminates in respiratory distress syndrome, primarily due to surfactant deficiency. Furthermore, the severity of this syndrome intensifies, particularly in the case of extremely premature neonates. This investigation aimed to evaluate the presence of postnatal pulmonary functional maturation in premature neonates. In pursuit of this objective, we conducted immunohistochemical assays for surfactant and Napsin A within the pulmonary tissue of 67 preterm neonates, with gestational ages ranging from 23 to 35 weeks, whose lifespans varied between one day and 149 days. The two immunohistochemical markers were evaluated within the pulmonary distal epithelium, and their expression was interpreted in relation to various pre- and postnatal factors. The examination was performed on tissue microarrays, sectioned at 5 micrometers, and the assessment of the immunohistochemical markers was interpreted from photographs captured under the optical microscope. Our investigation revealed that all neonates, regardless of their gestational age or lifespan, demonstrated the presence of surfactant within the pulmonary tissue. The intensity of Napsin A expression exhibited a positive correlation with gestational age, duration of oxygen therapy/mechanical ventilation, administration of antenatal corticosteroids, and maternal infections during pregnancy. In summary, our research demonstrated that mechanical ventilation, through the dynamic process of alveolar distension, promotes surfactant production within the distal lung epithelium. Antenatal treatment with corticosteroids and maternal antenatal infections enhances pulmonary function, facilitating surfactant production.

摘要

在肺功能成熟之前早产导致的肺发育中断最终会引发呼吸窘迫综合征,主要原因是表面活性剂缺乏。此外,该综合征的严重程度会加剧,尤其是在极早产儿的情况下。本研究旨在评估早产新生儿出生后肺功能成熟的情况。为实现这一目标,我们对67例胎龄在23至35周之间、寿命在1天至149天之间的早产新生儿的肺组织进行了表面活性剂和Napsin A的免疫组织化学检测。在肺远端上皮内评估这两种免疫组织化学标志物,并根据各种产前和产后因素对其表达进行解读。检测在5微米厚的组织微阵列上进行,免疫组织化学标志物的评估是根据光学显微镜下拍摄的照片进行解读的。我们的研究表明,所有新生儿,无论其胎龄或寿命如何,肺组织内均存在表面活性剂。Napsin A表达强度与胎龄、氧疗/机械通气持续时间、产前使用皮质类固醇以及孕期母体感染呈正相关。总之,我们的研究表明,机械通气通过肺泡扩张的动态过程促进肺远端上皮内表面活性剂的产生。产前使用皮质类固醇治疗和母体产前感染可增强肺功能,促进表面活性剂的产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/12207692/1e0d82789538/JMedLife-18-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/12207692/b2b4b528f857/JMedLife-18-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/12207692/1e0d82789538/JMedLife-18-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/12207692/b2b4b528f857/JMedLife-18-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/12207692/1e0d82789538/JMedLife-18-478-g002.jpg

相似文献

1
Distal pulmonary epithelial maturation in preterm infants: does the lung of the preterm infant continue its functional pulmonary development postnatally?早产儿远端肺上皮成熟:早产儿的肺在出生后是否继续其功能性肺发育?
J Med Life. 2025 May;18(5):478-486. doi: 10.25122/jml-2025-0072.
2
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
3
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.择期剖宫产术前应用产前皮质激素以改善新生儿结局。
Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4.
4
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.早期使用表面活性剂并进行短暂通气与选择性使用表面活性剂及持续机械通气用于患有或有呼吸窘迫综合征风险的早产儿的比较。
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003063. doi: 10.1002/14651858.CD003063.pub3.
5
Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.吸入性与全身性皮质类固醇治疗机械通气的极低出生体重早产儿慢性肺部疾病的比较
Cochrane Database Syst Rev. 2007 Oct 17(4):CD002057. doi: 10.1002/14651858.CD002057.pub2.
6
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.用于加速早产风险女性胎儿肺成熟的产前皮质类固醇。
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3.
7
Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.吸入性糖皮质激素与全身性糖皮质激素治疗极低出生体重早产儿慢性肺部疾病的比较
Cochrane Database Syst Rev. 2003(2):CD002057. doi: 10.1002/14651858.CD002057.
8
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.表面活性物质治疗在有呼吸窘迫综合征风险的早产儿中根据肺成熟度检测指导。
Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD013158. doi: 10.1002/14651858.CD013158.pub2.
9
Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.吸入性糖皮质激素与全身性糖皮质激素治疗机械通气的极低出生体重早产儿慢性肺部疾病的比较
Cochrane Database Syst Rev. 2012 May 16(5):CD002057. doi: 10.1002/14651858.CD002057.pub3.
10
Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews.干预措施管理新生儿暂时性呼吸急促 - 系统评价概述。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013563. doi: 10.1002/14651858.CD013563.pub2.

本文引用的文献

1
Association of Fetal Lung Development Disorders with Adult Diseases: A Comprehensive Review.胎儿肺发育障碍与成人疾病的关联:综述
J Pers Med. 2024 Mar 29;14(4):368. doi: 10.3390/jpm14040368.
2
Preterm birth affects both surfactant synthesis and lung liquid resorption actors in fetal sheep.早产会影响胎儿羊肺部表面活性剂合成和肺液吸收因子。
Dev Biol. 2024 Feb;506:64-71. doi: 10.1016/j.ydbio.2023.12.002. Epub 2023 Dec 9.
3
Antenatal steroids: benefits, risks, and new insights.产前类固醇:益处、风险和新见解。
J Endocrinol. 2023 Jun 26;258(2). doi: 10.1530/JOE-22-0306. Print 2023 Aug 1.
4
Fetal Programming: Lung Health and Disease.胎儿编程:肺部健康与疾病
Turk Thorac J. 2021 Sep;22(5):413-417. doi: 10.5152/TurkThoracJ.2021.0196.
5
Antenatal Betamethasone Induces Increased Surfactant Proteins and Decreased Foxm1 Expressions in Fetal Rabbit Pups.产前倍他米松诱导胎兔肺泡表面活性蛋白增加和叉头框转录因子 M1 表达减少。
Int J Med Sci. 2021 Jul 25;18(15):3367-3372. doi: 10.7150/ijms.62286. eCollection 2021.
6
Napsin A Expression in Human Tumors and Normal Tissues. napsin A 在人类肿瘤及正常组织中的表达。
Pathol Oncol Res. 2021 Apr 20;27:613099. doi: 10.3389/pore.2021.613099. eCollection 2021.
7
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.产前皮质类固醇用于加速有早产风险的孕妇的胎儿肺成熟。
Cochrane Database Syst Rev. 2020 Dec 25;12(12):CD004454. doi: 10.1002/14651858.CD004454.pub4.
8
Mechanical ventilation-induced alterations of intracellular surfactant pool and blood-gas barrier in healthy and pre-injured lungs.机械通气引起的健康肺和损伤前肺中细胞内表面活性物质池及血气屏障的改变。
Histochem Cell Biol. 2021 Feb;155(2):183-202. doi: 10.1007/s00418-020-01938-x. Epub 2020 Nov 13.
9
Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions.Napsin A 在不同胎龄正常人类胎儿肺组织及获得性和先天性肺部病变中的免疫组化表达。
Virchows Arch. 2020 Oct;477(4):557-563. doi: 10.1007/s00428-020-02809-5. Epub 2020 Apr 8.
10
Human lung development: recent progress and new challenges.人类肺脏发育:最新进展与新挑战。
Development. 2018 Aug 15;145(16):dev163485. doi: 10.1242/dev.163485.